Qishen Granule (QSG) Inhibits Monocytes Released From the Spleen and Protect Myocardial Function via the TLR4-MyD88-NF-κB p65 Pathway in Heart Failure Mice

Preliminary clinical and basic researches have proved that Qishen granule (QSG) is an effective prescription for treating heart failure (HF) in China, with a characteristic of regulating the ratio of M1/M2 macrophage in the myocardium. However, the regulative mechanism of monocytes targeting the car...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanqin, Li, Xuan, Chen, Xu, Sun, Xiaoqian, Liu, Xiangning, Wang, Gang, Liu, Yizhou, Cui, Lingwen, Liu, Tianhua, Wang, Wei, Wang, Yong, Li, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964526/
https://www.ncbi.nlm.nih.gov/pubmed/35370707
http://dx.doi.org/10.3389/fphar.2022.850187

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964526/
https://www.ncbi.nlm.nih.gov/pubmed/35370707
http://dx.doi.org/10.3389/fphar.2022.850187

Ejemplares similares